Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Sanda

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Urology|July 1, 1994
Genetic susceptibility of benign prostatic hyperplasiaM G Sanda, T H Beaty, R E Stutzman, et al.
Journal of Immunological Methods|July 15, 1991
Identification of unique murine tumor associated antigens by tumor infiltrating lymphocytes using tumor specific secretion of interferon-gamma and tumor necrosis factorR J Barth, J J Mulé, A L Asher, et al.
Urology|January 11, 2000
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancerJ T Wei, R L Dunn, M S Litwin, et al.
Urology|June 7, 2000
Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancerR Marcovich, K J Wojno, J T Wei, et al.
Urology|November 9, 2000
Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factorsR Shah, N Bassily, J Wei, et al.
Cancer Research|February 24, 2001
Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostateM G Rashid, M G Sanda, C J Vallorosi, et al.
Urology|November 1, 1994
Concordance rates for benign prostatic disease among twins suggest hereditary influenceA W Partin, W F Page, B R Lee, et al.
The Journal of Urology|August 8, 2001
Assessment of early continence recovery after radical prostatectomy: patient reported symptoms and impairmentS Kielb, R L Dunn, M G Rashid, et al.
The Prostate|May 15, 2001
Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cellsM M Taj, R J Tawil, L D Engstrom, et al.
Journal of the National Cancer Institute|February 15, 1995
Molecular characterization of defective antigen processing in human prostate cancerM G Sanda, N P Restifo, J C Walsh, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Urology|July 1, 1994
Genetic susceptibility of benign prostatic hyperplasiaM G Sanda, T H Beaty, R E Stutzman, et al.
Journal of Immunological Methods|July 15, 1991
Identification of unique murine tumor associated antigens by tumor infiltrating lymphocytes using tumor specific secretion of interferon-gamma and tumor necrosis factorR J Barth, J J Mulé, A L Asher, et al.
Urology|January 11, 2000
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancerJ T Wei, R L Dunn, M S Litwin, et al.
Urology|June 7, 2000
Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancerR Marcovich, K J Wojno, J T Wei, et al.
Urology|November 9, 2000
Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factorsR Shah, N Bassily, J Wei, et al.
Cancer Research|February 24, 2001
Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostateM G Rashid, M G Sanda, C J Vallorosi, et al.
Urology|November 1, 1994
Concordance rates for benign prostatic disease among twins suggest hereditary influenceA W Partin, W F Page, B R Lee, et al.
The Journal of Urology|August 8, 2001
Assessment of early continence recovery after radical prostatectomy: patient reported symptoms and impairmentS Kielb, R L Dunn, M G Rashid, et al.
The Prostate|May 15, 2001
Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cellsM M Taj, R J Tawil, L D Engstrom, et al.
Journal of the National Cancer Institute|February 15, 1995
Molecular characterization of defective antigen processing in human prostate cancerM G Sanda, N P Restifo, J C Walsh, et al.
Pageof 4